Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/17/2884478/0/en/Viracta-Therapeutics-Announces-New-Employment-Inducement-Grants.html
https://www.globenewswire.com/news-release/2024/05/14/2881219/0/en/Viracta-Therapeutics-Appoints-Michael-Faerm-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/05/09/2879191/0/en/Viracta-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/07/2877207/0/en/Viracta-Therapeutics-to-Present-at-the-RBC-Capital-Markets-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/04/15/2862733/0/en/Viracta-Therapeutics-Announces-Positive-Topline-Nana-val-Results-from-Stage-1-of-the-NAVAL-1-Trial-in-Patients-with-Relapsed-or-Refractory-Epstein-Barr-Virus-Positive-EBV-Periphera.html
https://www.globenewswire.com/news-release/2024/04/01/2855187/0/en/Viracta-Therapeutics-to-Present-Topline-Nana-val-Results-from-Stage-1-of-the-NAVAL-1-Trial-at-the-2024-Annual-Congress-of-The-Hematology-Society-of-Taiwan.html
https://www.globenewswire.com//news-release/2024/03/07/2842746/0/en/Viracta-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/29/2837928/0/en/Viracta-Therapeutics-Announces-Completion-of-Second-Stage-Enrollment-into-the-Peripheral-T-Cell-Lymphoma-Cohort-of-the-NAVAL-1-Trial.html
https://www.globenewswire.com//news-release/2024/02/06/2824716/0/en/Viracta-Therapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/01/04/2803921/0/en/Viracta-Therapeutics-Provides-Clinical-Update-and-Outlook-for-2024.html